JOHN P NORRIS M.D.
Prescription History 1346357779
Obstetrics & Gynecology in Franklin, IN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOHN P NORRIS M.D., an active Obstetrics & Gynecology specialist practicing in Franklin, IN. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 89 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 40 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IN PrescribersVs. IN Avg |
|---|---|---|---|
| Estradiol | 40 | $62.17 | ▲ More than typical |
About Estradiol: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 40 Medicare prescriptions for Estradiol, about 1.4 times the volume of the typical Indiana prescriber of this medication (28). Medicare paid an average of $62.17 per fill, versus $55.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 95.7 30-Day Fills standardized to 30-day supplies 2,841 Days of Medication total across all patients in 2023 | |||
| Raloxifene Hcl | 17 | $100.10 | ≈ Typical |
About Raloxifene Hcl: Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. Show more ▾ It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue. In 2023, this provider wrote 17 Medicare prescriptions for Raloxifene Hcl, about 85% of the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $100.10 per fill, versus $98.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2023 | |||
| YuvafemEstradiol | 17 | $127.94▼ below IN avg | ≈ Typical |
About Yuvafem: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 17 Medicare prescriptions for Yuvafem, about 85% of the volume of the typical Indiana prescriber of this medication (20). Medicare paid an average of $127.94 per fill, versus $139.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 29.8 30-Day Fills standardized to 30-day supplies 876 Days of Medication total across all patients in 2023 | |||
| PremarinEstrogens, Conjugated | 15 | $333.54▼ below IN avg | ≈ Typical |
About Premarin: This medication is a female hormone. Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. In 2023, this provider wrote 15 Medicare prescriptions for Premarin, about 88% of the volume of the typical Indiana prescriber of this medication (17). Medicare paid an average of $333.54 per fill, versus $406.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IN average for this medication. 23 30-Day Fills standardized to 30-day supplies 690 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JOHN P NORRIS M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Franklin, IN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
